StonvexLoading…
StonvexStonvexStonvexCore line items from BGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $408.94M | $1.83B | $1.29B | $849.83M |
Operating Income | $-10.96M | $97.15M | $68.90M | $57.88M |
Net Income | $-32.54M | $-43.26M | $-28.08M | $-9.77M |
EPS (Diluted) | $-0.41 | $-0.54 | $-0.35 | $-0.11 |
Total Assets | $2.84B | $2.83B | $2.94B | $2.94B |
Total Liabilities | $2.43B | $2.38B | $2.47B | $2.44B |
Cash & Equivalents | $64.54M | $56.29M | $60.91M | $54.08M |
Free Cash Flow OCF − CapEx | $18.72M | $70.75M | $-16.91M | $53.81M |
Shares Outstanding | 81.17M | 79.98M | 79.98M | 80.02M |